Transthyretin protects Alzheimer's mice from the behavioral and biochemical effects of Aβ toxicity
Open accessThe DOI matches its Crossref record; 31 of the 31 references it cites were found in a registry or an index.
Abstract
Cells that have evolved to produce large quantities of secreted proteins to serve the integrated functions of complex multicellular organisms are equipped to compensate for protein misfolding. Hepatocytes and plasma cells have well developed chaperone and proteasome systems to ensure that secreted proteins transit the cell efficiently. The number of neurodegenerative disorders associated with protein misfolding suggests that neurons are particularly sensitive to the pathogenic effects of aggregates of misfolded molecules because those systems are less well developed in this lineage. Aggregates of the amyloidogenic (Aβ 1–42 ) peptide play a major role in the pathogenesis of Alzheimer's disease (AD), although the precise mechanism is unclear. In genetic studies examining protein–protein interactions that could constitute native mechanisms of neuroprotection in vivo , overexpression of a WT human transthyretin (TTR) transgene was ameliorative in the APP23 transgenic murine model of human AD. Targeted silencing of the endogenous TTR gene accelerated the development of the neuropathologic phenotype. Intraneuronal TTR was seen in the brains of normal humans and mice and in AD patients and APP23 mice. The APP23 brains showed colocalization of extracellular TTR with Aβ in plaques. Using surface plasmon resonance we obtained in vitro evidence of direct protein–protein interaction between TTR and Aβ aggregates. These findings suggest that TTR is protective because of its capacity to bind toxic or pretoxic Aβ aggregates in both the intracellular and extracellular environment in a chaperone-like manner. The interaction may represent a unique normal host defense mechanism, enhancement of which could be therapeutically useful.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Genome-wide atlas of gene expression in the adult mouse brain
Lein, E. S., Hawrylycz, M. J., Ao, N., Ayres, M., Bensinger, A., Bernard, A., Boe, A. F., Boguski, M. S., Brockway, K. S., Byrnes, E. J., et al. (2007) · Nature · doi:10.1038/nature05453 · Cited by 5,572
Brain interleukin 1 and S-100 immunoreactivity are elevated in Down syndrome and Alzheimer disease.
Griffin, W. S., Stanley, L. C., Ling, C., White, L., MacLeod, V, Perrot, L. J., White, C. L., & Araoz, C. (1989) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.86.19.7611 · Cited by 1,777 · cited 1×
“Local cytokine production has been shown in AD brain (29).”
BackgroundTwo amyloid precursor protein transgenic mouse models with Alzheimer disease-like pathology
Sturchler-Pierrat, C., Abramowski, D., Duke, M., Wiederhold, K.-H., Mistl, C., Rothacher, S., Ledermann, B., Bürki, K., Frey, P., Paganetti, P. A., et al. (1997) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.94.24.13287 · Cited by 1,507
Expression of human beta-amyloid peptide in transgenic Caenorhabditis elegans.
Link, C. D. (1995) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.92.20.9368 · Cited by 687
Serum insulin-like growth factor I regulates brain amyloid-β levels
Carro, E., Trejo, J. L., Gomez-Isla, T., LeRoith, D., & Torres-Aleman, I. (2002) · Nature Medicine · doi:10.1038/nm1202-793 · Cited by 440
Transthyretin sequesters amyloid beta protein and prevents amyloid formation.
Schwarzman, A. L., Gregori, L., Vitek, M. P., Lyubski, S., Strittmatter, W. J., Enghilde, J. J., Bhasin, R., Silverman, J., Weisgraber, K. H., & Coyle, P. K. (1994) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.91.18.8368 · Cited by 413
Reixach, N., Deechongkit, S., Jiang, X., Kelly, J. W., & Buxbaum, J. N. (2004) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0400062101 · Cited by 392
Self-citationEpiskopou, V, Maeda, S., Nishiguchi, S., Shimada, K., Gaitanaris, G. A., Gottesman, M. E., & Robertson, E. J. (1993) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.90.6.2375 · Cited by 325
Stein, T. D., & Johnson, J. A. (2002) · The Journal of Neuroscience · doi:10.1523/jneurosci.22-17-07380.2002 · Cited by 288
Stein, T. D., Anders, N. J., DeCarli, C., Chan, S. L., Mattson, M. P., & Johnson, J. A. (2004) · The Journal of Neuroscience · doi:10.1523/jneurosci.2211-04.2004 · Cited by 277
Levites, Y. (2005) · Journal of Clinical Investigation · doi:10.1172/jci25410 · Cited by 207
Preparation of Amyloid β‐Protein for Structural and Functional Studies
Teplow, D. B. (2006) · Methods in Enzymology · doi:10.1016/s0076-6879(06)13002-5 · Cited by 184
Adult mouse brain gene expression patterns bear an embryologic imprint
Zapala, M. A., Hovatta, I., Ellison, J. A., Wodicka, L., Del Rio, J. A., Tennant, R., Tynan, W., Broide, R. S., Helton, R., Stoveken, B. S., et al. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0503357102 · Cited by 183
Chronic Corticosterone Impairs Memory Performance in the Barnes Maze
McLay, R. N., Freeman, S. M., & Zadina, J. E. (1998) · Physiology & Behavior · doi:10.1016/s0031-9384(97)00529-5 · Cited by 164
Transthyretin is involved in depression‐like behaviour and exploratory activity
Sousa, J. C., Grandela, C., Fernández‐Ruíz, J., de Miguel, R., de Sousa, L., Magalhães, A., Saraiva, M. J., Sousa, N., & Palha, J. A. (2004) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.2003.02309.x · Cited by 159
Yan, C., Costa, R. H., Darnell, J. E., Jr., Chen, J. D., & Dyke, T. A. V. (1990) · The EMBO Journal · doi:10.1002/j.1460-2075.1990.tb08184.x · Cited by 151
Transthyretin: A key gene involved in the maintenance of memory capacities during aging
Brouillette, J., & Quirion, R. (2007) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2007.04.007 · Cited by 145
Accelerated A Deposition in APPswe/PS1 E9 Mice with Hemizygous Deletions of TTR (Transthyretin)
Choi, S. H., Leight, S. N., Lee, V. M.-Y., Li, T., Wong, P. C., Johnson, J. A., Saraiva, M. J., & Sisodia, S. S. (2007) · Journal of Neuroscience · doi:10.1523/jneurosci.1919-07.2007 · Cited by 140
Goodman, A. B. (2006) · Journal of Cellular Physiology · doi:10.1002/jcp.20784 · Cited by 138
Inhibitory Deficits, Delay Aversion and Preschool AD/HD:Implications for the Dual Pathway Model
Dalen, L., Sonuga-Barke, E. J. S., Hall, M., & Remington, B. (2004) · Neural Plasticity · doi:10.1155/np.2004.1 · Cited by 122
Behavioral phenotyping of rodents.
Crawley, J. N. (2003) · PubMed · Cited by 117
Shirahama, T., Skinner, M. M., Westermark, P., Rubinow, A., Cohen, A. S., Brun, A., & Kemper, T. L. (1982) · PubMed Central · Cited by 114
Transthyretin and Alzheimer's disease: Where in the brain?
Sousa, J. C., Cardoso, I., Marques, F., Saraiva, M. J., & Palha, J. A. (2007) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2006.03.015 · Cited by 114
Teng, M.-H., Yin, J.-Y., Vidal, R., Ghiso, J. A., Kumar, A. R., Rabenou, R. A., Shah, A., Jacobson, D. R., Tagoe, C. E., Gallo, G., et al. (2001) · Laboratory Investigation · doi:10.1038/labinvest.3780246 · Cited by 112
Self-citationTransthyretin influences spatial reference memory
Sousa, J. C., Marques, F., Dias-Ferreira, E., Cerqueira, J., Sousa, N., & Palha, J. A. (2007) · Neurobiology of Learning and Memory · doi:10.1016/j.nlm.2007.07.006 · Cited by 102
Thyroid hormone metabolism in a transthyretin-null mouse strain
Palha, J. A., Episkopou, V, Maeda, S., Shimada, K., Gottesman, M. E., & Saraiva, M. J. (1994) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(20)30107-1 · Cited by 93
Kinetics of Inhibition of β-Amyloid Aggregation by Transthyretin
Liu, L., & Murphy, R. M. (2006) · Biochemistry · doi:10.1021/bi0618520 · Cited by 80
Amyloidogenic and anti-amyloidogenic properties of recombinant transthyretin variants
Schwarzman, A. L., Tsiper, M. V., Wente, H., Wang, A., Vitek, M. P., Vasiliev, V. B., & Goldgaber, D. (2004) · Amyloid · doi:10.1080/13506120410001667458 · Cited by 67
The Evolution of Transthyretin Synthesis in the Choroid Plexus
Schreiber, G. (2002) · Clinical Chemistry and Laboratory Medicine (CCLM) · doi:10.1515/cclm.2002.210 · Cited by 56
The nature and origin of amyloid fibrils
Bock, G. R., & Goode, J. A. (1996) · Medical Entomology and Zoology · Cited by 54
Aged APP23 mice show a delay in switching to the use of a strategy in the Barnes maze
Prut, L., Abramowski, D., Krucker, T., Levy, C. L., Roberts, A. J., Staufenbiel, M., & Wießner, C. (2007) · Behavioural Brain Research · doi:10.1016/j.bbr.2007.01.017 · Cited by 42
Self-citation
Cited by
Amyloid β Protein and Alzheimer’s Disease: When Computer Simulations Complement Experimental Studies
Nasica-Labouze, J., Nguyen, P. H., Sterpone, F., Berthoumieu, O., Buchete, N.-V., Coté, S., De Simone, A., Doig, A. J., Faller, P., Garcia, A., et al. (2015) · Chemical Reviews · doi:10.1021/cr500638n · Cited by 584
Biology and pathophysiology of the amyloid precursor protein
Zheng, H., & Koo, E. H. (2011) · Molecular Neurodegeneration · doi:10.1186/1750-1326-6-27 · Cited by 348
Johnson, S. M., Connelly, S., Fearns, C., Powers, E. T., & Kelly, J. W. (2012) · Journal of Molecular Biology · doi:10.1016/j.jmb.2011.12.060 · Cited by 328
Blood–brain-barriers in aging and in Alzheimer’s disease
Marques, F., Sousa, J. C., Sousa, N., & Palha, J. A. (2013) · Molecular Neurodegeneration · doi:10.1186/1750-1326-8-38 · Cited by 274
Transthyretin: A multifaceted protein
Vieira, M., & Saraiva, M. J. (2014) · BioMolecular Concepts · doi:10.1515/bmc-2013-0038 · Cited by 185
Metadata
- Authors
- Buxbaum, J. N., Ye, Z., Reixach, N., Friske, L., Levy, C., Das, P., Golde, T., Masliah, E., Roberts, A. R., & Bartfai, T.
- Venue
- Proceedings of the National Academy of Sciences
- Published
- 2008-02-19
- Volume
- 105
- Issue
- 7
- Pages
- 2681-2686
- ISSN
- 0027-8424 (ISSN-L)
- 1091-6490
- OpenAlex
- W1978632887
- Cited by
- 284
- References
- 31
- FWCI
- 11.66
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.